Heparin interactions. Heparin: Uses, Dosage, Side Effects, and Interactions – A Comprehensive Guide
What are the primary uses of heparin. How is heparin dosage determined. What are the common side effects of heparin. Which drugs interact with heparin. What precautions should be taken when using heparin.
Understanding Heparin: An Essential Anticoagulant
Heparin is a widely used anticoagulant medication that plays a crucial role in preventing blood clots. This powerful drug has numerous applications in medical practice, but it also comes with important considerations regarding its use, dosage, potential side effects, and interactions with other substances.
The Therapeutic Applications of Heparin
Heparin is primarily used to prevent and treat blood clots in various medical scenarios. Its main applications include:
- Prevention of deep vein thrombosis (DVT) and pulmonary embolism
- Treatment of existing blood clots
- Use during certain medical procedures, such as dialysis or heart surgery
- Management of acute coronary syndromes
- Prevention of clotting in intravenous lines and catheters
When is heparin typically prescribed? Heparin is often used in hospital settings for patients who are at high risk of developing blood clots due to immobility, surgery, or certain medical conditions. It’s also used in the initial treatment of blood clots before transitioning to oral anticoagulants.
Heparin Dosage: A Delicate Balance
Determining the correct dosage of heparin is critical for its effectiveness and safety. The dosage varies depending on several factors:
- The patient’s weight
- The specific medical condition being treated
- The route of administration (intravenous or subcutaneous)
- The patient’s response to the medication
How is heparin dosage monitored? Healthcare providers closely monitor the effects of heparin using blood tests that measure clotting time, such as the activated partial thromboplastin time (aPTT) or anti-Factor Xa levels. These tests help ensure that the anticoagulation effect is within the therapeutic range.
Typical Dosage Forms
Heparin is available in various concentrations, typically measured in units per milliliter (units/mL). Common formulations include:
- 1,000 units/mL
- 5,000 units/mL
- 10,000 units/mL
The choice of concentration depends on the specific clinical situation and the required dose.
Side Effects: What to Watch For
While heparin is an effective medication, it can cause several side effects. Some of the most common include:
- Bleeding or bruising
- Pain or irritation at the injection site
- Allergic reactions
- Thrombocytopenia (low platelet count)
- Osteoporosis (with long-term use)
What is the most serious side effect of heparin? The most concerning side effect is excessive bleeding, which can be life-threatening. Patients and healthcare providers must be vigilant for signs of unusual bleeding or bruising.
Rare but Serious Side Effects
In rare cases, heparin can cause more severe complications, such as:
- Heparin-induced thrombocytopenia (HIT), a potentially dangerous immune reaction
- Severe allergic reactions, including anaphylaxis
- Priapism (prolonged erection)
These rare side effects require immediate medical attention.
Heparin Interactions: A Complex Web
Heparin can interact with numerous other medications, potentially altering its effectiveness or increasing the risk of side effects. According to the information provided, there are 224 known drug interactions with heparin, categorized as follows:
- 58 major interactions
- 143 moderate interactions
- 23 minor interactions
Which drugs have major interactions with heparin? Some of the medications with major interactions include:
- Warfarin (Coumadin)
- Apixaban (Eliquis)
- Enoxaparin (Lovenox)
- Clopidogrel (Plavix)
These interactions can significantly increase the risk of bleeding and require careful management by healthcare providers.
Alcohol and Food Interactions
While the specific alcohol/food interaction is not detailed in the provided information, it’s important to note that there is one known interaction. Patients taking heparin should discuss any alcohol consumption or dietary concerns with their healthcare provider.
Disease Interactions and Precautions
Heparin has known interactions with seven medical conditions:
- Peptic ulcer disease
- Active bleeding
- Hypertension
- Prematurity
- Renal dysfunction
- Thrombocytopenia
- Hyperkalemia
Why are these disease interactions important? These conditions can increase the risks associated with heparin use or affect its metabolism in the body. For example, patients with active bleeding or a high risk of bleeding (such as those with peptic ulcers) may be at increased risk of complications from heparin therapy.
Special Populations
Extra caution is needed when using heparin in certain groups of patients:
- Elderly patients, who may be more sensitive to the effects of heparin
- Pregnant women, as heparin can cross the placenta
- Patients with liver or kidney disease, which can affect heparin metabolism
Healthcare providers must carefully weigh the benefits and risks of heparin therapy in these populations.
Monitoring and Managing Heparin Therapy
Given the potential for interactions and side effects, close monitoring is essential for patients on heparin therapy. This typically involves:
- Regular blood tests to assess coagulation status
- Monitoring for signs of bleeding or bruising
- Adjusting dosage based on test results and clinical response
- Educating patients about potential side effects and when to seek medical attention
How often should patients on heparin be monitored? The frequency of monitoring depends on the specific clinical situation, but it often involves daily blood tests, especially when initiating therapy or adjusting dosages.
Managing Adverse Effects
If adverse effects occur, management strategies may include:
- Dose adjustment
- Temporary or permanent discontinuation of heparin
- Administration of protamine sulfate to reverse heparin’s effects in cases of severe bleeding
- Switching to alternative anticoagulants if necessary
Prompt recognition and management of adverse effects are crucial for patient safety.
Alternative Anticoagulants and Future Directions
While heparin remains a cornerstone of anticoagulation therapy, several alternatives are available:
- Low molecular weight heparins (e.g., enoxaparin)
- Direct oral anticoagulants (DOACs) such as apixaban, rivaroxaban, and dabigatran
- Fondaparinux, a synthetic pentasaccharide
These alternatives may offer advantages in certain clinical situations, such as easier administration or reduced monitoring requirements.
What advancements are being made in anticoagulation therapy? Research is ongoing to develop new anticoagulants with improved safety profiles and more specific targeting of coagulation factors. Additionally, efforts are being made to create reversal agents for newer anticoagulants, enhancing their safety in clinical use.
Personalized Anticoagulation
The future of anticoagulation therapy is likely to involve more personalized approaches, taking into account individual patient factors such as:
- Genetic variations affecting drug metabolism
- Comorbidities and concomitant medications
- Lifestyle factors and patient preferences
This personalized approach aims to optimize the balance between preventing thrombosis and minimizing bleeding risks.
In conclusion, heparin remains a vital medication in the prevention and treatment of blood clots. Its effective use requires a thorough understanding of its applications, dosing considerations, potential side effects, and interactions. As medical knowledge advances, the management of anticoagulation therapy continues to evolve, promising more tailored and safer approaches to preventing thrombotic events.
Heparin Interactions Checker – Drugs.com
Save
There are 224 drugs known to interact with
heparin, along with
7 disease interactions, and 1 alcohol/food interaction.
Of the total drug interactions,
58 are major, 143 are moderate, and 23 are minor.
Does heparin interact with my other drugs?
Enter other medications to view a detailed report.
- View all 224 medications that may interact with heparin
- View heparin alcohol/food interactions (1)
- View heparin disease interactions (7)
Most frequently checked interactions
View interaction reports for heparin and the medicines listed below.
- Major
- Moderate
- Minor
- Unknown
- Ativan (lorazepam)
- Benadryl (diphenhydramine)
- Cardizem (diltiazem)
- Colace (docusate)
- Combivent (albuterol / ipratropium)
- Coumadin (warfarin)
- Dilaudid (hydromorphone)
- Eliquis (apixaban)
- Lantus (insulin glargine)
- Lasix (furosemide)
- Lipitor (atorvastatin)
- Lopressor (metoprolol)
- Lovenox (enoxaparin)
- MiraLAX (polyethylene glycol 3350)
- Norco (acetaminophen / hydrocodone)
- Normal Saline Flush (sodium chloride)
- Norvasc (amlodipine)
- Paracetamol (acetaminophen)
- Percocet (acetaminophen / oxycodone)
- Phenergan (promethazine)
- Plavix (clopidogrel)
- Protonix (pantoprazole)
- Rocephin (ceftriaxone)
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Zofran (ondansetron)
Heparin alcohol/food interactions
There is 1 alcohol/food interaction with heparin.
Heparin disease interactions
There are 7 disease interactions with heparin which include:
- peptic ulcer disease
- active bleeding
- hypertension
- prematurity
- renal dysfunction
- thrombocytopenia
- hyperkalemia
Report options
Loading…
QR code containing a link to this page
More about heparin
- heparin consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: heparins
- Breastfeeding
- En español
Related treatment guides
- Angina
- Anticoagulation During Pregnancy
- Antiphospholipid Syndrome
- Deep Vein Thrombosis
Drug Interaction Classification
Major | Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. |
---|---|
Moderate | Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. |
Minor | Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. |
Unknown | No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Medical Disclaimer
Heparin (Porcine) Injection: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: Shape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 20,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 20,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 20,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL (1 mL) injection cartridge
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 20,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL injection solution
Color: clearShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 10,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 1,000 unit/mL injection solution
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
heparin (porcine) 5,000 unit/mL (1 mL) injection cartridge
Color: colorlessShape: Imprint:
This medicine is a colorless, clear, vial
Heparin sodium drug interactions with other drugs (compatibility) | Vidal.
ru
Heparin sodium drug interactions with other drugs (compatibility) | Vidal.ru – a directory of medicines
|
Our website uses cookies to improve your user experience and performance, as well as marketing activities.
By continuing, you agree to the use of cookies.
Ok
Order a drug
💊 Composition of the drug Heparin ✅ Use of the drug Heparin Save Search for analogues Interaction Description of the active ingredients of the preparation Heparin The scientific information provided is general and cannot be used to make decisions. Update date: 2019.12.04 Marketing authorization holder: SYNTHESIS JSC ATX code: B01AB01 (Heparin) Active substance: Rec. INN WHO registered Dosage form
Release form, packaging and composition |
D59.3 | Hemolytic uremic syndrome |
D65 | Disseminated intravascular coagulation [defibrination syndrome] |
I20.0 | Unstable angina |
I21 | Acute myocardial infarction |
I26 | Pulmonary embolism |
I33.9 | Acute endocarditis, unspecified |
I34. 0 | Mitral (valvular) insufficiency |
I48 | Atrial fibrillation and flutter |
I74 | Arterial embolism and thrombosis |
I80 | Phlebitis and thrombophlebitis |
I82 | Embolism and thrombosis of other veins |
N00 | Acute nephritic syndrome (acute glomerulonephritis) |
N03 | Chronic nephritic syndrome |
N08.5 | Glomerular lesions in systemic connective tissue diseases |
Z51.4 | Preparatory procedures for subsequent treatment or examination, not elsewhere classified |
Dosing regimen
The method of administration and dosing regimen of a particular drug depends on its form of release and other factors. The optimal dosage regimen is determined by the doctor. Compliance of the dosage form of a particular drug with indications for use and dosing regimen should be strictly observed.
Individual, depending on the dosage form used, indications, clinical situation and age of the patient.
Side effects
On the part of the blood coagulation system: possible bleeding of the gastrointestinal tract and urinary tract, bleeding at the injection site, in areas subjected to pressure, from surgical wounds, as well as hemorrhages in other organs, hematuria, thrombocytopenia.
From the digestive system: nausea, loss of appetite, vomiting, diarrhea, increased activity of liver transaminases.
Allergic reactions: flushing of the skin, drug fever, urticaria, rhinitis, pruritus and sensation of heat in the soles, bronchospasm, collapse, anaphylactic shock.
On the part of the blood coagulation system: thrombocytopenia (may be severe up to death) with subsequent development of skin necrosis, arterial thrombosis, accompanied by the development of gangrene, myocardial infarction, stroke.
From the musculoskeletal system: with prolonged use – osteoporosis, spontaneous fractures, soft tissue calcification.
Local reactions: irritation, pain, hyperemia, hematoma and ulceration at the injection site.
Other: transient alopecia, hypoaldosteronism.
Contraindications for use
Bleeding, diseases accompanied by impaired blood coagulation, suspected intracranial hemorrhage, cerebral aneurysm, hemorrhagic stroke, dissecting aortic aneurysm, antiphospholipid syndrome, malignant arterial hypertension, subacute bacterial endocarditis, erosive ulcerative lesions of the gastrointestinal tract , severe lesions of the liver parenchyma, cirrhosis of the liver with varicose veins of the esophagus, malignant neoplasms in the liver, shock conditions, recent surgical interventions on the eyes, brain, prostate, liver and biliary tract, condition after spinal cord puncture, menstruation, threatened miscarriage, childbirth (including recent), hypersensitivity to heparin.
Use during pregnancy and lactation
Use during pregnancy is possible only under strict indications, under close medical supervision.
Contraindication: threatened miscarriage, childbirth (including recent).
Can be used during breastfeeding if indicated.
Use for violations of liver function
Contraindications: severe lesions of the liver parenchyma, cirrhosis of the liver with varicose veins of the esophagus, malignant neoplasms in the liver.
Use for impaired renal function
Used when indicated in patients with severe kidney disease.
Use in children
May be used in children if indicated.
Use in elderly patients
Use with caution in elderly patients (over 60 years, especially in women).
Special instructions
Use with caution in patients suffering from polyvalent allergies (including bronchial asthma), arterial hypertension, dental procedures, diabetes mellitus, endocarditis, pericarditis, in the presence of an intrauterine contraceptive, with active tuberculosis, radiation therapy, liver failure, chronic renal failure, in elderly patients (over 60 years, especially women).
IM administration of heparin is not recommended due to the possibility of developing a hematoma, as well as IM administration of other drugs during treatment with heparin.
Use with caution externally for bleeding and conditions of increased bleeding, thrombocytopenia.
During treatment with heparin, monitoring of blood coagulation parameters is necessary.
Only normal saline is used to dilute heparin.
With the development of severe thrombocytopenia (a decrease in the number of platelets by 2 times from the original number or below 100,000 / µl), heparin should be urgently discontinued.
The risk of bleeding can be minimized with careful evaluation of contraindications, regular laboratory monitoring of blood clotting, and adequate dosing.
Drug interactions
The anticoagulant effect of heparin is enhanced by the simultaneous use of anticoagulants, antiplatelet agents and NSAIDs.
Ergot alkaloids, thyroxine, tetracycline, antihistamines, and nicotine reduce the effect of heparin.